Quest Diagnostics Inc. Earnings

Quest Diagnostics Inc.’s revenue jumped 14.55% since last year same period to $2621Mn in the Q4 2024. On a quarterly growth basis, Quest Diagnostics Inc. has generated 5.35% jump in its revenue since last 3-months.

Quest Diagnostics Inc.’s net profit jumped 15.63% since last year same period to $222Mn in the Q4 2024. On a quarterly growth basis, Quest Diagnostics Inc. has generated -1.77% fall in its net profits since last 3-months.

Quest Diagnostics Inc.’s net profit margin jumped 0.93% since last year same period to 8.47% in the Q4 2024. On a quarterly growth basis, Quest Diagnostics Inc. has generated -6.75% fall in its net profit margins since last 3-months.

Quest Diagnostics Inc.’s price-to-earnings ratio after this Q4 2024 earnings stands at 21.24.

Quest Diagnostics Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.18 - a -3.35% fall from last quarter’s estimates.

Quest Diagnostics Inc.’s earning per share (EPS) estimates for the current year stand at 2.18.

Quest Diagnostics Inc.’s earning per share (EPS) jumped 3.72% since last year same period to 2.23 in the Q4 2024. This indicates that the Quest Diagnostics Inc. has generated 3.72% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Quest Diagnostics Inc.’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Quest Diagnostics Inc.’s return on equity (ROE) stands at 0.13.

Quest Diagnostics Inc. declared 0.75 dividend per share during the earnings announcement for Q4 2024.